retatrutide nonalcoholic fatty liver disease trial nash Researchers report promising results with retatrutide, which significantly reduced fat in some patients over several months. Excess liver fat causes metabolic dysfunction–associated steatotic retatrutide nonalcoholic fatty liver disease

Although use of these products is generally considered safe and well-tolerated, further research is needed to assess any long-term effects

are taking or have taken medicines called monoamine oxidase inhibitors (MAOIs) in the past 14 days

Prevent deficiencies in calcium, magnesium, iron, and vitamin D

L-Carnitine vs Creatine: Which is Better

Understanding glutathione myths and facts is essential for making informed wellness decisions

PMC: Comparative Safety of GLP-1/GIP Co-Agonists Versus GLP-1 Receptor Agonists for Weight Loss. New England Journal of Medicine: Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. PMC: Who Wins the Battle Against Obesity